Biobanking, Genetics, Genomics and Medicine - Clinical Research Informer

UK agency pilots biobank to study links between genetics and drug side effects

Pharmaceutical Technology

MAY 25, 2023

The Medicines and Healthcare products Regulatory Agency (MHRA) aims to launch a pilot genetic biobank that will gather patient data to associate drug-related adverse events to their genetic makeup. The Yellow Card biobank will launch as a joint venture with the UK-government funded entity Genomics England on June 1.

Biobanking

Biobanking Genetics Genome Project Genome

What are the key trends in genomics and precision medicine for 2024?

Drug Discovery World

JANUARY 29, 2024

Leading experts in genomics, personalised medicine and drug discovery convened at the Precision Medicine Community Event in London to unveil the latest advancements shaping the future of healthcare. The post What are the key trends in genomics and precision medicine for 2024?

Genome

Genome Genomics Medicine Biobanking

Why genomic healthcare data matters in the development of new therapies

Drug Discovery World

NOVEMBER 7, 2022

Genomic healthcare data is critical to identify disease risk, ancestry, traits and response to medicines and aids in the development of new targeted therapies – precision medicines. In April 2003, after its launch in October 1990, the project was completed, generating the first sequence of the human genome.

Genome

Genome Genomics Development Genetics

A new dawn of the genomic age: five areas set to be transformed in 2023

pharmaphorum

JANUARY 26, 2023

2022 was a banner year for genomics. In March, the collaborative T2T consortium published the first complete telomere-to-telomere sequence of the human genome, filling in the last 8% of the 3 billion base pairs that make up our DNA.

Genome

Genome Genomics Genome Project Genetics

Why early participant engagement is now a top priority in genetic disease research

pharmaphorum

JANUARY 18, 2023

In 2016, scientists behind a study called the Resilience Project analysed genetic data from 589,000+ people and found 13 adults who carried genetic variants that should have resulted in serious – even deadly – childhood disease, but who were apparently healthy. Giving participants something in return.

Genetic Disease

Genetic Disease Genetics Research Genome

Can genetic data be a magic bullet for drug R&D?

pharmaphorum

JANUARY 24, 2023

Ben Hargreaves finds that the vast amount of genetic data that exists today could help provide a faster, more targeted way of developing new drug candidates. The logical extension to this kind of approach is treating individual patients, with their individual genetic makeup.

Genetics

Genetics Drugs Genome Project Biobanking

Qatar Genome Programme data improves cancer screening

Drug Discovery World

OCTOBER 26, 2022

A study by the Qatar Genome Research Consortium, led by Dr Lotfi Chouchane from Weill Cornell Medicine-Qatar, has reported the first landscape of cancer germline mutations – hereditary mutations – in the Qatari population. . These variants increase the risk of developing breast cancer in women and prostate cancer in men. .

Genome

Genome Genomics Biobanking Genetics

San Diego zoo global biobanking advances wildlife conservation and human medicine worldwide

Scienmag

NOVEMBER 12, 2020

In a study that has unprecedented implications to advance both medicine and biodiversity conservation, researchers have sequenced 131 new placental mammal genomes, bringing the worldwide total to more than 250 In a study that has unprecedented implications to advance both medicine and biodiversity conservation, researchers have sequenced 131 new placental (..)

Biobanking

Biobanking Medicine Genome Genomics

Drug discovery hotspots: Focus on Qatar

Drug Discovery World

MARCH 7, 2023

Qatar’s pharmaceutical and healthcare markets, whilst receiving significant government attention, are still within their beginnings.

Biobanking

Biobanking Drugs Genome Genomics

GSK pumps £30m into a new Oxford University partnership

pharmaphorum

DECEMBER 2, 2021

GlaxoSmithKline has formed a five-year partnership with Oxford University to set up a new institute that will apply machine learning and functional genomics to the discovery of new medicines. ” The post GSK pumps £30m into a new Oxford University partnership appeared first on.

Biobanking

Biobanking Genome Genomics Genetics

Estonia National Biobank to sequence 10,000 whole genomes

Drug Discovery World

APRIL 4, 2024

The university will also support the European Union’s 1+ Million Genomes initiative, which seeks to boost innovation in healthcare across Europe. Driving new understanding 10,000 whole human genomes will be sequenced and analysed by the Institute of Genomics at the University of Tartu.

Biobanking

Biobanking Genome Genomics Genome Project

Collaboration between AbbVie, Biogen and Pfizer creates world’s largest browsable resource linking rare protein-coding genetic variants to human health and disease

The Pharma Data

JULY 15, 2021

The access to the world’s largest browsable resource linking rare protein-coding genetic variants to human health and disease was launched through a genetic exome sequence analysis collaboration between AbbVie (NYSE: ABBV), Biogen Inc. Nasdaq: BIIB) and Pfizer (NYSE: PFE).

Biobanking

Biobanking Genetics Protein Medicine

Biorepositories as a Guiding Resource for Research & Drug Discovery

XTalks

FEBRUARY 4, 2021

The power of leveraging clinical data to decipher disease mechanisms and fuel drug discovery has rapidly grown in the era of genomics and personalized medicine. Biobanks are used for the coordination of high-yield patient sample collection. Partnerships and Establishing Research Cohorts.

Research

Research Biobanking Drugs Genome

WORLD’S LARGEST BROWSABLE RESOURCE LINKING RARE PROTEIN-CODING GENETIC VARIANTS TO HUMAN HEALTH AND DISEASE

The Pharma Data

JULY 8, 2021

Today, access to the world’s largest browsable resource linking rare protein-coding genetic variants to human health and disease was launched through a genetic exome sequence analysis collaboration between AbbVie (NYSE: ABBV), Biogen Inc. Nasdaq: BIIB) and Pfizer (NYSE: PFE). The browser can be accessed via [link]. About AbbVie.

Genetics

Genetics Biobanking Protein Containment

How biomarkers can help discover new treatments for women’s health

Drug Discovery World

OCTOBER 30, 2023

We previously conducted a hypothesis-free study using genotype data from the UK Biobank, which resulted in the first mechanism-based stratification of endometriosis patients. RA: How will this data improve the chances of finding novel precision medicines for endometriosis?

Genome

Genome Genomics Genotype Clinical Trials

Clinical Research Informer

UK agency pilots biobank to study links between genetics and drug side effects

What are the key trends in genomics and precision medicine for 2024?

Trending Sources

Why genomic healthcare data matters in the development of new therapies

A new dawn of the genomic age: five areas set to be transformed in 2023

Why early participant engagement is now a top priority in genetic disease research

Can genetic data be a magic bullet for drug R&D?

Qatar Genome Programme data improves cancer screening

San Diego zoo global biobanking advances wildlife conservation and human medicine worldwide

Drug discovery hotspots: Focus on Qatar

GSK pumps £30m into a new Oxford University partnership

Estonia National Biobank to sequence 10,000 whole genomes

Collaboration between AbbVie, Biogen and Pfizer creates world’s largest browsable resource linking rare protein-coding genetic variants to human health and disease

Biorepositories as a Guiding Resource for Research & Drug Discovery

WORLD’S LARGEST BROWSABLE RESOURCE LINKING RARE PROTEIN-CODING GENETIC VARIANTS TO HUMAN HEALTH AND DISEASE

How biomarkers can help discover new treatments for women’s health

Stay Connected